MDM2 Overexpression Modulates the Angiogenesis-Related Gene Expression Profile of Prostate Cancer Cells

The Murine Double Minute 2 (MDM2) amplification or overexpression has been found in many tumors with high metastatic and angiogenic ability. Our experiments were designed to explore the impact of MDM2 overexpression, specifically on the levels of angiogenesis-related genes, which can also play a maj...

Full description

Bibliographic Details
Main Authors:	Thiagarajan Venkatesan, Ali Alaseem, Aiyavu Chinnaiyan, Sivanesan Dhandayuthapani, Thanigaivelan Kanagasabai, Khalid Alhazzani, Priya Dondapati, Saad Alobid, Umamaheswari Natarajan, Ruben Schwartz, Appu Rathinavelu
Format:	Article
Language:	English
Published:	MDPI AG 2018-05-01
Series:	Cells
Subjects:	MDM2 THBS1 MMP9 Angiogenesis LNCaP-MST PCR array Nutlin-3
Online Access:	http://www.mdpi.com/2073-4409/7/5/41

Similar Items

Integrative analysis of transcriptomic and metabolomic profiles reveals enhanced arginine metabolism in androgen-independent prostate cancer cells
by: Xingchen Dai, et al.
Published: (2023-12-01)

Antiproliferative and apoptotic effects of pinocembrin in human prostate cancer cells
by: Zhenyu Chen, et al.
Published: (2013-05-01)

KAT5 Negatively regulates the proliferation of prostate cancer LNCaP cells via the caspase 3-dependent apoptosis pathway
by: Chul-Hong Kim, et al.
Published: (2019-07-01)

Clinical overview of MDM2/X targeted therapies
by: Andrew eBurgess, et al.
Published: (2016-01-01)

MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters
by: Kester Mo Henningsen, et al.
Published: (2021-12-01)

Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma
by: Joon Hee Kang, et al.
Published: (2020-06-01)

Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor–specific inhibitor
by: Appu Rathinavelu, et al.
Published: (2017-11-01)

Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?
by: Lucia Haronikova, et al.
Published: (2021-12-01)

Effects of Apelin-13 on Human Prostate Cancer Lines [Insan Prostat Kanseri Hucre Serilerinde Apelin-13un Etkileri]
by: Suat Tekin, et al.
Published: (2014-09-01)

Prostatic Therapeutic Efficacy of LENILUTS<sup>®</sup>, a Novel Formulation with Multi-Active Principles
by: Erik Tedesco, et al.
Published: (2022-09-01)

Characterization of camptothecin by analytical methods and determination of anticancer potential against prostate cancer
by: Sunil T. Galatage, et al.
Published: (2021-05-01)

Fibroblast Growth Factor-1 Induced Promatrilysin Expression Through the Activation of Extracellular-regulated Kinases and STAT3
by: Thirupandiyur S. Udayakumar, et al.
Published: (2002-01-01)

Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core
by: Daniil R. Bazanov, et al.
Published: (2022-04-01)

Is Irisin an Anticarcinogenic Peptide?
by: Suat Tekin, et al.
Published: (2015-06-01)

The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells
by: Reem T. Attia, et al.
Published: (2016-06-01)

In Vitro Pro-apoptotic and Anti-migratory Effects of Ficus deltoidea L. Plant Extracts on the Human Prostate Cancer Cell Lines PC3
by: Mohd M. M. Hanafi, et al.
Published: (2017-12-01)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
by: Ximing Li, et al.
Published: (2020-06-01)

Establishment of an orthotopic prostate cancer xenograft mouse model using microscope-guided orthotopic injection of LNCaP cells into the dorsal lobe of the mouse prostate
by: Weiyong Liu, et al.
Published: (2022-02-01)

MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma
by: Arianna Romani, et al.
Published: (2022-10-01)

Methoxyphenyl Imidazolines as Potential Activators of p53
by: Daniil R. Bazanov, et al.
Published: (2022-11-01)

TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response
by: Chiao-En Wu, et al.
Published: (2019-03-01)

Title Changes in the Mineral Composition of Rat Femoral Bones Induced by Implantation of LNCaP Prostate Cancer Cells and Dietary Supplementation
by: Dorota Skrajnowska, et al.
Published: (2020-12-01)

The Natural Chemotherapeutic Capsaicin Activates AMPK through LKB1 Kinase and TRPV1 Receptors in Prostate Cancer Cells
by: Belén G. Sánchez, et al.
Published: (2022-01-01)

Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer
by: Francesca Corsi, et al.
Published: (2022-01-01)

Isolation and Structural Characterization of Bioactive Molecules on Prostate Cancer from Mayan Traditional Medicinal Plants
by: Rafael Sebastián Fort, et al.
Published: (2018-08-01)

Ailanthone: a new potential drug for castration-resistant prostate cancer
by: Shihong Peng, et al.
Published: (2017-03-01)

Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity
by: Sander Bekeschus, et al.
Published: (2020-04-01)

Zeolite Nanoparticles Loaded with 2-Methoxystradiol as a Novel Drug Delivery System for the Prostate Cancer Therapy
by: Denisse Mena-Silva, et al.
Published: (2023-06-01)

The transcriptomic response of cells to a drug combination is more than the sum of the responses to the monotherapies
by: Jennifer EL Diaz, et al.
Published: (2020-09-01)

Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase
by: Belén G. Sánchez, et al.
Published: (2019-03-01)

A Mathematical Investigation of the Multiple Pathways to Recurrent Prostate Cancer: Comparison with Experimental Data
by: Trachette L. Jackson
Published: (2004-11-01)

Induction of Apoptosis and Growth Suppression by Homeobox Gene TGIFLX in Prostate Cancer Cell Line Lncap.
by: Zahra Rashvand, et al.
Published: (2013-11-01)

Suppression of ANT2 by miR-137 Inhibits Prostate Tumorigenesis
by: Heyuan Zhang, et al.
Published: (2021-09-01)

Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation
by: Giorgio Zauli, et al.
Published: (2022-07-01)

Cell Cycle Arrest and Cytotoxic Effects of SAHA and RG7388 Mediated through p21<sup>WAF1/CIP1</sup> and p27<sup>KIP1</sup> in Cancer Cells
by: Umamaheswari Natarajan, et al.
Published: (2019-01-01)

Ciliary Neurotrophic Factor Modulates Multiple Downstream Signaling Pathways in Prostate Cancer Inhibiting Cell Invasiveness
by: Giovanni Tossetta, et al.
Published: (2022-11-01)

Resistance to 2-Hydroxy-Flutamide in Prostate Cancer Cells Is Associated with the Downregulation of Phosphatidylcholine Biosynthesis and Epigenetic Modifications
by: José María Mora-Rodríguez, et al.
Published: (2023-10-01)

A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells
by: Amalia Luce, et al.
Published: (2022-12-01)

Synthesis of Pregnane Derivatives, Their Cytotoxicity on LNCap and PC-3 Cells, and Screening on 5α-Reductase Inhibitory Activity
by: Sujeong Kim, et al.
Published: (2009-11-01)

Structure based virtual screening, docking and molecular dynamic simulation studies to identify potent mdm2-p53 inhibitors: Future implications for cancer therapy
by: B Vijay Raj, et al.
Published: (2017-01-01)